U.S. Metals and Mining Stock News

Why Hawkins (HWKN) Is On Investors’ Radar Recent trading in Hawkins (HWKN) has drawn attention after the stock’s recent month and past 3 months performance, prompting investors to reassess what the current price of $167.01 implies. With returns of 13.88% over the past month and 24.28% in the past 3 months, Hawkins’ recent move sits against a backdrop of longer term total returns and a business spanning water treatment, industrial chemicals, and health and nutrition ingredients. See our latest...

Aurinia Pharmaceuticals (AUPH) has drawn fresh attention after reporting first quarter 2026 results. Revenue was US$77.71 million and net income was US$34.36 million, both higher than the prior year period. See our latest analysis for Aurinia Pharmaceuticals. The earnings beat and reiterated 2026 guidance arrived alongside a 4.9% 90 day share price return and an 86.7% 1 year total shareholder return, suggesting strong recent momentum despite short term share price weakness. If Aurinia’s...

Earnings and dividend announcement set the tone for Crown Holdings stock Crown Holdings (CCK) recently reported first quarter 2026 results alongside an affirmation of its regular quarterly dividend, giving investors fresh information on both the company’s operating performance and its ongoing cash return policy. See our latest analysis for Crown Holdings. The recent earnings release, which showed quarterly sales of US$3,259 million and net income of US$175 million, together with the affirmed...

Cimpress plc has reported past third-quarter 2026 results showing sales of US$886.21 million versus US$789.47 million a year earlier, with net income of US$13.84 million compared with a net loss of US$8.24 million and basic earnings per share from continuing operations improving from US$0.33 loss to US$0.57. Over the first nine months to March 31, 2026, Cimpress lifted sales to US$2.79 billion and more than doubled net income to US$70.82 million, highlighting materially stronger...

Walker & Dunlop, Inc. has reported past first-quarter 2026 results, with revenue rising to US$301.33 million and net income to US$15.87 million, alongside affirming a quarterly dividend of US$0.68 per share payable on June 4, 2026. Beneath these headline figures, the company highlighted very large growth in transaction volumes and agency lending, supported by complex refinancing deals and higher productivity per banker that helped increase its share of the GSE lending market. We’ll now...

What recent returns say about MakeMyTrip stock MakeMyTrip (MMYT) has moved sharply in recent months, with a 2.1% gain over the past day, about 7% over the past week, and roughly 32% over the past month. See our latest analysis for MakeMyTrip. While the recent 32% 1 month share price return points to strong short term momentum, this comes after a 38.3% year to date share price decline and a 48% 1 year total shareholder return loss, set against much stronger 3 and 5 year total shareholder...

Armstrong World Industries (AWI) has put investors on alert after its first quarter 2026 update, combining higher year-on-year sales, slightly lower net income and a reaffirmed full year net sales outlook. See our latest analysis for Armstrong World Industries. The reaffirmed 2026 net sales outlook and management's focus on M&A have come after a 16.7% decline in the 90 day share price return, even as the 3 year total shareholder return sits at 157.8%. This suggests long term momentum has been...

Jacobs Solutions (NYSE:J) has been selected as part of a joint venture to design five new underground stations for Sydney Metro West. The contract covers integrated engineering design services for Australia’s largest transportation project. The win expands Jacobs Solutions’ global transportation infrastructure footprint, with a focus on high-performance, sustainable mass transit. For investors watching the infrastructure and engineering space, this new Sydney Metro West mandate puts Jacobs...

Pebblebrook Hotel Trust stock moves draw investor focus Pebblebrook Hotel Trust (PEB) is back on many investors’ radars after a recent stretch of positive share price performance, with the stock up over the past month and past 3 months. See our latest analysis for Pebblebrook Hotel Trust. That recent upswing fits into a broader recovery story, with a 30 day share price return of 13.88% and a 1 year total shareholder return of 53.71% pointing to improving momentum despite a weak 5 year total...

Why Chemours stock is on investors’ radar Chemours (CC) has drawn fresh attention after its first quarter 2026 earnings, where several business segments outperformed expectations, and management highlighted debt reduction, refinancing activity, and reaffirmed full year sales and EBITDA guidance. See our latest analysis for Chemours. That interest has come against a sharp pullback in recent days, with a 1 day share price return of 5.32% decline and a 7 day share price return of 16.85% decline,...

Stepan Company reported past first-quarter 2026 results showing sales of US$604.51 million versus US$593.26 million a year earlier, but it swung from net income of US$19.71 million to a net loss of US$41.41 million, with basic and diluted loss per share from continuing operations of US$1.81 compared with earnings of US$0.86. Despite the move into loss-making territory, Stepan maintained its shareholder payout by affirming a quarterly dividend of US$0.395 per share, payable on June 15, 2026,...

The Kraft Heinz Company recently reported first-quarter 2026 results, with sales of US$6,047 million, net income of US$798 million, basic EPS of US$0.67, a US$13 million goodwill and intangible impairment, and affirmed a quarterly dividend of US$0.40 per share payable on June 26, 2026. Alongside early progress in its turnaround under new CEO Steve Cahillane, the company has completed a US$1.51 billion share repurchase program and launched a US$1.10 billion tender offer to reshape its...

Doximity (DOCS) is back in focus after its share price reacted to shifting analyst forecasts ahead of the upcoming earnings release, with investors weighing expectations for lower EPS against modest revenue growth. See our latest analysis for Doximity. The stock has staged a short term rebound, with a 7 day share price return of 6.51% and a 30 day share price return of 15.69%. However, this sits against a year to date share price return decline of 39.87% and a 1 year total shareholder return...

In April 2026, Seacoast Banking Corporation of Florida reported first-quarter 2026 results, with net interest income rising to US$176.47 million from US$118.52 million a year earlier, while net income was broadly flat at US$31.9 million and diluted EPS from continuing operations eased to US$0.29 from US$0.37. Over the same quarter, Seacoast also completed a buyback of 317,628 shares for US$10.23 million, a small but clear signal of ongoing capital return alongside its mixed earnings...

IHS Holding (NYSE:IHS) has completed the divestment of its 51% stake in Brazilian fiber infrastructure venture I-Systems. The stake has been sold to TIM S.A., marking IHS Holding's exit from this Brazilian optical fiber joint venture. IHS Holding, trading at $8.23, has seen its stock return 12.0% year to date and 44.1% over the past year, while its 3 year return stands at 9.2%. This completed I-Systems divestment gives investors a fresh development to consider alongside those share price...

If you are wondering whether Merit Medical Systems is starting to look interesting at its current share price, this article focuses squarely on what that price might imply about value. The stock last closed at US$62.33, with recent returns of an 8.6% decline over 7 days, a 7.5% decline over 30 days, a 27.9% decline year to date, and a 35.1% decline over the past year. These moves have put the stock back on many watchlists, as investors reassess what they are willing to pay for medical...

nCino recently won significant banking clients, including being selected by Raiffeisenbankengruppe Oesterreich as its unified corporate lending platform and by Vision Credit Union to modernize agricultural and commercial lending with AI-enabled tools. These client wins, alongside new leadership appointments such as a Chief Revenue Officer and Asia-Pacific Managing Director, highlight nCino’s push to deepen international reach and scale its AI-focused banking platform. We’ll now look at how...

What recent performance says about Clover Health Investments (CLOV) Clover Health Investments (CLOV) has attracted fresh attention after a sharp share price move, with the stock showing a 5.2% gain over the past day and a 48.4% gain over the past month. See our latest analysis for Clover Health Investments. The recent 48.4% 1-month share price return sits against a 17.0% share price return year to date and a 24.8% decline in the 1-year total shareholder return. This points to momentum...

Jabil (JBL) is back in focus as investors look ahead to its upcoming earnings report, with expectations for higher earnings per share and revenue helping to fuel fresh interest in the stock. See our latest analysis for Jabil. The recent 1-day share price return of -6.11% to US$349.60 comes after a 30-day share price return of 28.13% and a 1-year total shareholder return of 126.78%. This points to strong momentum with some short term volatility as investors position around earnings...

Albemarle (NYSE:ALB) held its annual shareholder meeting on May 5, 2026. Shareholders approved the board slate, executive compensation package, and auditor ratification. A proposal to remove supermajority provisions for certain affiliated transactions narrowly did not pass. Shareholders backed a proposal to make it easier for investors to call special meetings. Albemarle, a major producer in the lithium and specialty chemicals space, sits at the center of debates around corporate governance...

In the first quarter of 2026, Live Nation Entertainment reported sales of US$3,793.03 million, but a net loss of US$389.1 million as a US$450 million legal accrual tied to investigations and litigation pushed the company into an operating loss. At the same time, the long-running Popp v. Live Nation and Ticketmaster nationwide class action over allegedly supracompetitive ticketing fees advanced, while management emphasized double-digit adjusted operating income growth expectations and record...

Encompass Health (EHC) stock is in focus after first quarter 2026 results topped Wall Street expectations, management raised full year revenue and adjusted EPS guidance, and the company continued expanding its inpatient rehabilitation hospital network. See our latest analysis for Encompass Health. The recent 1 day share price return of 2.0% to $107.15 and 7 day share price return of 7.2% suggest momentum has picked up following the earnings beat, higher guidance, new hospital opening and...

EPR Properties’ recently reported first-quarter 2026 results showed revenue rising to US$181.25 million and funds from operations growth, even as net income and earnings per share edged lower compared with a year earlier. Alongside the earnings, EPR closed or advanced a US$315.00 million acquisition of a Seven Flags regional attractions portfolio and lifted its annual investment spending plans, underscoring management’s commitment to experiential real estate expansion and portfolio...

In recent days, LTX, an AI-powered corporate bond e-trading venue backed by Broadridge, announced that J.P. Morgan joined as a fully integrated liquidity provider, while JPMorgan Chase expanded its fixed-income issuance, rolled out new youth-focused banking tools, and deepened partnerships in data, private credit and tokenized settlement. Together, these moves highlight JPMorgan’s push to shape next-generation bond and digital markets even as CEO Jamie Dimon publicly flags risks of a...